HIKMA Pharmaceuticals PLC
Develops & markets affordable generic & specialty medicines for markets in NA, MENA, & Europe.
HIK | IL
Overview
Corporate Details
- ISIN(s):
- GB00B0LCW083
- LEI:
- 549300BNS685UXH4JI75
- Country:
- United Kingdom
- Address:
- 1 New Burlington Place, W1S 2HR London
- Website:
- https://www.hikma.com/home/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Hikma Pharmaceuticals PLC is a multinational generics and specialty pharmaceutical company that develops, manufactures, and markets a broad range of high-quality medicines. For nearly 50 years, its core mission has been to make medications accessible and affordable for patients. The company's portfolio includes branded and non-branded generics, as well as in-licensed products. Hikma serves retail and hospital customers across its primary markets in North America, the Middle East & North Africa (MENA), and Europe, leveraging its manufacturing footprint and local presence to enhance healthcare access.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-22 13:02 |
Director's Dealing
Director/PDMR Shareholding
|
English | 14.5 KB | ||
| 2025-08-13 14:51 |
Director's Dealing
Director/PDMR Shareholding
|
English | 17.9 KB | ||
| 2025-08-08 13:59 |
Director's Dealing
Director/PDMR Shareholding
|
English | 14.6 KB | ||
| 2025-08-07 08:00 |
Earnings Release
Half-year Report
|
English | 884.0 KB | ||
| 2025-07-09 10:00 |
Report Publication Announcement
Notice of Results
|
English | 12.9 KB | ||
| 2025-07-07 10:16 |
Report Publication Announcement
Publication of Offering Circular
|
English | 8.0 KB | ||
| 2025-06-05 15:05 |
Director's Dealing
Director/PDMR Shareholding
|
English | 14.4 KB | ||
| 2025-06-03 14:02 |
Director's Dealing
Director/PDMR Shareholding
|
English | 89.1 KB | ||
| 2025-05-29 08:00 |
Capital/Financing Update
Fitch upgrades Hikma to ‘BBB’
|
English | 11.3 KB | ||
| 2025-05-15 13:00 |
Earnings Release
Medium-term Group guidance ahead of US site visit
|
English | 12.5 KB | ||
| 2025-05-08 11:48 |
Regulatory News Service
S&P upgrades Hikma to ‘BBB’
|
English | 11.3 KB | ||
| 2025-05-08 09:21 |
Legal Proceedings Report
Settlement agreement for Xyrem® US lawsuits
|
English | 15.2 KB | ||
| 2025-04-30 14:21 |
Director's Dealing
Director/PDMR Shareholding
|
English | 27.3 KB | ||
| 2025-04-24 18:16 |
Post-Annual General Meeting Information
Special Business passed at AGM
|
English | 329.0 KB | ||
| 2025-04-24 16:55 |
Post-Annual General Meeting Information
Result of AGM
|
English | 48.9 KB |
Automate Your Workflow. Get a real-time feed of all HIKMA Pharmaceuticals PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for HIKMA Pharmaceuticals PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
